Viewing Study NCT01232556

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:15 PM

Ignite Modification Date: 2026-01-02 @ 9:32 AM

Study NCT ID: NCT01232556

Status: TERMINATED

Last Update Posted: 2019-01-08

First Post: 2010-10-27

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

Sponsor: Pfizer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module